Target intelligence / Profile preview

Neurotensin Receptor 2 (NTS2)

Target
NTS2
Molecular classification
G protein-coupled receptor, GPCR, Receptor, Class A GPCR
01

Overview

Neurotensin receptor 2 (NTS2), also known as NTR2, is a G protein-coupled receptor (GPCR) that primarily binds the neuropeptide neurotensin. It is involved in modulating several physiological processes, especially within the central nervous system, including dopamine signaling, pain modulation, and thermal regulation. Its unique pharmacology, particularly its high sensitivity to levocabastine and the development of selective synthetic ligands, makes it a promising target for non-opioid analgesics and potential treatments for psychiatric or neurological disorders.

Other names
NTR2NT2RLevocabastine-sensitive neurotensin receptorHigh-affinity levocabastine-sensitive neurotensin receptor
02

Mechanism of action

Activation of phosphatidylinositol-calcium second messenger system; competitive binding with neurotensin at the receptor site.

03

Biological functions

Signal transductionModulation of dopamine signalingRegulation of body temperaturePain modulationAntinociception
04

Disease associations

PainNeurological disordersPsychiatric disordersStress-related disorders
05

Safety considerations

Potential for off-target effects if selectivity is not achievedLimited understanding of long-term effects of selective NTS2 modulation
06

Interacting drugs

Neurotensin

1 more in the full profile.

Beyond the preview

Go deeper on Neurotensin Receptor 2 (NTS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurotensin Receptor 2 (NTS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call